Figure 3 from Dabogratinib (TYRA-300), an FGFR3 Isoform-Selective Inhibitor: Preclinical and Initial Clinical Evidence of Antitumor Activity
Authors:
- Jacqueline H. StarrettJSJacqueline H. Starrett
- Eric L. AllenEAEric L. Allen
- Melissa NealMNMelissa Neal
- Samhita IyerSISamhita Iyer
- Qing YeQYQing Ye
- Robert L. HudkinsRHRobert L. Hudkins
- Viraj DegaonkarVDViraj Degaonkar
- Christine LihouCLChristine Lihou
- Ronald V. SwansonRSRonald V. Swanson
- Valentina BoniVBValentina Boni
- Jesús Fuentes-AntrásJFJesús Fuentes-Antrás
- Cedric PobelCPCedric Pobel
Open Access
- 2 March 2026
- other
- Published by American Association for Cancer Research (AACR)